默沙东公布数据:Intismeran与Keytruda联用,可将复发或死亡风险压低58%;用药六个月时,远处转移或死亡风险较Keytruda单药方案缩减一半。
默沙东公布数据:Intismeran与Keytruda联用,可将复发或死亡风险压低58%;用药六个月时,远处转移或死亡风险较Keytruda单药方案缩减一半。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.